Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Galva Technologies Tbk. (GLVA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Galva Technologies Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Galva Technologies Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Galva Technologies Tbk. trades at Rp326 (market cap 492B, 3.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Galva Technologies Tbk. is far larger — about 3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 3.8K). Which is the better fit depends on your goals.

GLVAOBAT
Market Cap
492B166.01B
Volume
3.8K324K
Lot
383.24K
Turnover
1.23M77.68M
Average Price
322.53239.75
Value
1.23M77.68M
Indicative Equilibrium Price
328240
Indicative Equilibrium Volume
2001

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GLVA
View details
OBAT
View details

About Galva Technologies Tbk.

PT Galva Technologies Tbk (the “Company”) was established under the Deed No. 1 dated September 1, 1991 by notary Fransiscus Jacobus Mawati, S.H., notary in Jakarta.

Read more on GLVA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT